These various receptor-mediated events are directly dependent on the CXCL1 or CXCL2 concentration (75), and dysregulation of these processes e.g., in the pathogenesis of neuropathic pain could switch the cell phenotype. This evidence concerns the gene CXCL1 and Pain.